Freedom EVO automates tropical disease research
Tecan Trading AG
Freedom EVO platform
The Mahidol-Oxford Tropical Medicine Research Unit (MORU) in Thailand has chosen Tecan's Freedom EVO platform to automate research into the pharmacology of anti-malarial and anti-influenza drugs.
'Our studies focus on malaria and influenza, and the main thrust of our research is the development of new methods and assays to quantify these drugs in biological fluids,' said Prof Niklas Lindegardh, head of department.
'Our Freedom EVO liquid-handling workstation performs aliquoting and preparation of patient samples, automating a range of preparation methods, such as solid-phase or liquid-liquid extractions and protein precipitations,' he said.
'We have been able to move from performing all these steps manually to automating everything on the Freedom EVO 200 and analyses that previously took around five hours now take only 20min for 96 samples,' Lindegardh said.
'We have since been able to refine the scripts, creating new processes and fine tuning the system to accommodate our sample-preparation requirements,' he added.
Researchers in the Biology Department at the University of Konstanz, Germany, use Tecan's Multichannel Arm (MCA) 384 and Freedom EVO liquid handling platform to develop novel molecular tools.
Dr Francisco Quintana from the Harvard Medical School is using Tecan microarrays as part of a systems biology approach to studying the immune response in multiple sclerosis.
Euroscreen, a pre-clinical drug discovery company, has chosen Tecan's flexible Infinite F200 PRO multimode plate reader for a variety of screening applications in drug discovery and characterisation.
Scientists have used the 3D scanning capabilities of the Quad4 monochromators-based Infinite M1000 microplate reader to investigate nanobodies.
The HydroFlex microplate washer by Tecan has allowed hematologists at the University of Modena and Reggio Emilia in Italy to introduce automated washing for Enzyme-Linked ImmunoSpot (ELISpot) assays.